Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
05/08/2008 | DE202007018194U1 CGM Chitin-Glucan-Melanin Kaugummi CGM chitin-glucan gum melanin |
05/08/2008 | DE102006052504A1 Verfahren zum Herstellen eines Mittels gegen eine Infektionskrankheit A method for preparing an agent against an infectious disease |
05/08/2008 | DE102006051796A1 Triaza-benzo[e]azulenderivate Triaza-benzo [e] azulene derivatives |
05/08/2008 | CA2668537A1 Composition for the treatment of gastrointenstinal diseases |
05/08/2008 | CA2668020A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
05/08/2008 | CA2664430A1 Immunochemically equivalent hiv drug analogs |
05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
05/07/2008 | EP1918366A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
05/07/2008 | EP1918289A2 Crystalline fluoroquinolone arginine salt form |
05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
05/07/2008 | EP1917977A1 Therapeutic drug for heart disease and virus disease |
05/07/2008 | EP1917970A2 Hla binding peptides and their uses |
05/07/2008 | EP1917959A1 New medical use of alfa-ketoglutarate |
05/07/2008 | EP1917958A2 Improved HIV protease inhibitors pharmaceutical formulations |
05/07/2008 | EP1917019A2 Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection |
05/07/2008 | EP1814566A4 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds |
05/07/2008 | EP1545602B1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
05/07/2008 | EP1456651B1 Self-assembly molecules |
05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |
05/07/2008 | EP1141306B1 Streptococcus antigens |
05/07/2008 | CN101175752A Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate |
05/07/2008 | CN101175532A Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone |
05/07/2008 | CN101175531A Pharmaceutical combination comprising an antibacterial agent and an active substance selected from carveol, thymol, eugenol, borneol and carvacrol |
05/07/2008 | CN101175504A Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method |
05/07/2008 | CN101175491A Use of a sulfonamide compound for improving the pharmacokinetics of a drug |
05/07/2008 | CN101175474A Methods of reducing microbial contamination |
05/07/2008 | CN101175404A Method and composition for use in preparation of a patient for surgery |
05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
05/07/2008 | CN101173005A Insect antimicrobial peptide Thanatin derivant, producing method and uses of the same |
05/07/2008 | CN101172998A BASB111 polypeptide and polynucleotide from |
05/07/2008 | CN101172993A 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
05/07/2008 | CN101172981A 2,3-dihydroimidazo[2,1-b]oxazole compound |
05/07/2008 | CN101172980A Method for the preparation of hexahydro-furo 2,3-b furan-3-ol |
05/07/2008 | CN101172975A Method of preparing five-alkaloid composition of corydalis saxicola bunting |
05/07/2008 | CN101172957A Selective inhibitors of viral or bacterial neuraminidase |
05/07/2008 | CN101172161A Water-soluble polymers decorated G-CSF conjugates |
05/07/2008 | CN101172159A Acidic biological adhesion heat-variable gelling agent, its preparing method and uses |
05/07/2008 | CN101172157A Vibrio parahaemolyticus tunica externa protein ompK subunit vaccine and preparation method thereof |
05/07/2008 | CN101172153A Coptis chinensis, dried ginger contained traditional Chinese medicine mixture for treating HP masculine |
05/07/2008 | CN101172150A Externally used medicament for treating beriberi |
05/07/2008 | CN101172128A Globeflower tablet and preparing technique thereof |
05/07/2008 | CN101172127A Mulberry leaf extract and application of mulberry leaf extract in preparing anti-influenza A virus medicament |
05/07/2008 | CN101172118A Probiotics as alternative medicines against infectious diseases |
05/07/2008 | CN101172114A Application of sanitizer lanthanum nitrate for stopping sexual transmission of AIDS virus and venereal disease causal agent |
05/07/2008 | CN101172110A Application of 23-hydroxyl radical white birck acid in preparing medicament for treating or preventing intestinal canal tumour |
05/07/2008 | CN101172108A Prulifloxacin active body injection |
05/07/2008 | CN101172012A Medicine pillow for preventing and controlling common cold |
05/07/2008 | CN101171966A Medicinal food gruel for treating bacillary dysentery |
05/07/2008 | CN101171948A Health-care herb cool tea and its preparing method |
05/07/2008 | CN100386343C SARS virus S protein and N protein fusion protein, and preparation and use thereof |
05/07/2008 | CN100386319C Tetra hydro iso quinoline compounds possessing anti breed and anti fungus activity and its salt |
05/07/2008 | CN100386111C Recovery mixture for liver, gallbladder and stomach and its preparing method |
05/07/2008 | CN100386099C Peony astragalus polyglucoside composition for treating liver disease and its preparation method |
05/07/2008 | CN100386093C Medicine composition for treating cold and upper respiratory tract infection, preparation method and purpose thereof |
05/07/2008 | CN100386087C Use of kutkin I in preparing drug for treating hepatitis B |
05/07/2008 | CN100386086C Dispersed compound tablet of glycyrrhizic acid and glycyrrhizinate and its preparing process |
05/07/2008 | CN100386081C Injection containing tricyclofluoro quinolone sulfonate and its preparing method and use |
05/07/2008 | CN100386080C Tetrandrine solid lipide nano particle and its preparing method |
05/07/2008 | CN100386077C Coated norcantharidin tablet and its preparing method |
05/07/2008 | CN100386074C Retinoic acid and the like oral formulation |
05/07/2008 | CN100386072C Nanometer dragon's blood capsule and its preparation method |
05/07/2008 | CN100386069C Brilliant mycomycin elaioplast preparation and its making method |
05/07/2008 | CN100386024C Synergistic microbicidal combination |
05/06/2008 | US7368571 HIV-Integrase inhibitors, pharmaceutical compositions and methods for their use |
05/06/2008 | US7368557 Comprises DNA from RNA virus which codes for RNA polymerase and nonstructural protein in bacterial artificial chromosome; virions; gene therapy |
05/06/2008 | US7368556 Not pilC or gene involved in biosynthesis of polysaccharide capsule, IgA protease, pilin, protein which binds transferrin orlactoferrin; involved in colonization of nasopharynx or invasion of submucousal space; diagnosis and prevention of meningitis |
05/06/2008 | US7368460 Tropane derivatives useful in therapy |
05/06/2008 | US7368452 for complex formation of hepatitis C non-structural protein-3 (NS3) with NS4A; enhancing the proteolytic efficacy at all of the sites; prevent reproduction of hepatitis virus |
05/06/2008 | US7368287 For treatment and/or prevention of inflammation and autoimmune disease; vaccines |
05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
05/06/2008 | US7368261 Conserved Neisserial antigens |
05/06/2008 | US7368244 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
05/06/2008 | US7368144 Removal of shell, pulp; grinding in presence of solvent; macerating, extraction. filtration |
05/06/2008 | US7368136 Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
05/06/2008 | US7368116 Method of enhancing a targeted immune response against tumors |
05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
05/06/2008 | CA2463619C Stabilized azithromycin compositions |
05/06/2008 | CA2322229C Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity |
05/06/2008 | CA2283868C Photosensitizer conjugates for pathogen targeting |
05/06/2008 | CA2280727C Bicyclic amino acids |
05/06/2008 | CA1341572C Protective antibodies to serotypic determinants of flagellar antigens |
05/02/2008 | WO2008051637A2 Pyridazinone compounds |
05/02/2008 | WO2008051416A2 Compounds that inhibit the activity of hsp90 for treating infections |
05/02/2008 | WO2008050910A1 Grifola frondosa-origin substance having antiinfluenza virus activity and method of producing the same |
05/02/2008 | WO2008050907A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
05/02/2008 | WO2008050871A1 Crystalline carbapenem compounds |
05/02/2008 | WO2008050858A1 Amide compound, salt thereof, and biofilm remover using them |
05/02/2008 | WO2008050857A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
05/02/2008 | WO2008050830A1 Anti-hiv agent |
05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
05/02/2008 | WO2008050707A1 Pharmaceutical agent and extract for use in the pharmaceutical |
05/02/2008 | WO2008049974A2 Peptide vaccine for influenza virus |
05/02/2008 | WO2008049950A1 Novel polynitrogenated systems as anti-hiv agents |
05/02/2008 | WO2008049855A2 7-azaindole derivatives as c-met kinase inhibitors |
05/02/2008 | WO2008030511A3 Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes |
05/02/2008 | WO2008010098A3 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
05/02/2008 | WO2008005565A3 Antiviral phosphinate compounds |